Concepedia

Catherine Fagard

CF

Statistics

Publications

27

Citations

1.4K

H-Index

21

Active since

2000

Affiliations

Inserm(Current)

Assistance Publique – Hôpitaux de Paris

Bordeaux Population Health

Université Paris Cité

Hôpital Saint-Louis

Catherine Fagard is an author at Inserm specializing in antiretroviral therapy, antiviral therapy, and infectious diseases.

Publications per year

2000–2018

27

Publications

27

High Rate of Virologic Suppression with Raltegravir plus Etravirine and Darunavir/Ritonavir among Treatment‐Experienced Patients Infected with Multidrug‐Resistant HIV: Results of the ANRS 139 TRIO Trial

Yazdan Yazdanpanah, Catherine Fagard, Diane Descamps et al. · Clinical Infectious Diseases · 2009 · 237 citations

, , +17

Stimulation of HIV-specific cellular immunity by structured treatment interruption fails to enhance viral control in chronic HIV infection

Annette Oxenius, David A. Price, Huldrych F. Günthard et al. · Proceedings of the National Academy of Sciences · 2002 · 214 citations

, , +15

A Prospective Trial of Structured Treatment Interruptions in Human Immunodeficiency Virus Infection

Catherine Fagard · Archives of Internal Medicine · 2003 · 177 citations · Full text

, , +14

Raltegravir for the treatment of patients co-infected with HIV and tuberculosis (ANRS 12 180 Reflate TB): a multicentre, phase 2, non-comparative, open-label, randomised trial

Beatriz Grinsztejn, Nathalie De Castro, Vincent Arnold et al. · The Lancet Infectious Diseases · 2014 · 98 citations

, , +12

Proviral HIV-DNA predicts viral rebound and viral setpoint after structured treatment interruptions

Sabine Yerly, Huldrych F. Günthard, Catherine Fagard et al. · AIDS · 2004 · 76 citations

, , +17

1–5 of 27